<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>ANAVEX LIFE SCIENCES 1 RSS Feed | Nachrichten - www.finanzen.net</title><description>www.finanzen.net bietet Finanznachrichten zum weltweiten Börsengeschehen</description><category>Finanzen</category><link>https://www.finanzen.net</link><language>de-de</language><copyright>finanzen.net GmbH</copyright><lastBuildDate>Sat, 04 Apr 2026 06:21:29 +0200</lastBuildDate><atom:link href="https://www.finanzen.net/rss/anavex%5Flife%5Fsciences%5F1%2Drss%2Dfeed" rel="self" type="application/rss+xml"/><image><url>https://images.finanzen.net/images/finanzen_net_neu.gif</url><title>ANAVEX LIFE SCIENCES 1 RSS Feed | Nachrichten - www.finanzen.net</title><link>https://www.finanzen.net</link></image><item><title>Anavex Life Sciences: Bilanz zum abgelaufenen Quartal</title><pubDate>Tue, 10 Feb 2026 06:35:06 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/anavex-life-sciences-bilanz-zum-abgelaufenen-quartal-15476199</link><description><![CDATA[<p><a href="https://www.finanzen.net/aktien/anavex_life_sciences_1-aktie">Anavex Life Sciences</a> hat am 09.02.2026 Zahlen zum jüngsten Quartal vorgelegt, das am 31.12.2025 endete.Dabei wurde ein Verlust je Aktie von 0,06 USD ausgewiesen. Im Vorjahresquartal waren -0,140 USD je  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/anavex-life-sciences-bilanz-zum-abgelaufenen-quartal-15476199</guid></item><item><title>INVESTIGATION ALERT: Edelson Lechtzin LLP Announces an Investigation of Anavex Life Sciences Corp. (NASDAQ: AVXL) and Encourages Investors with Substantial Losses Contact the Firm</title><pubDate>Fri, 09 Jan 2026 02:13:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/investigation-alert-edelson-lechtzin-llp-announces-an-investigation-of-anavex-life-sciences-corp-nasdaq-avxl-and-encourages-investors-with-substantial-losses-contact-the-firm-15404013</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">NEWTOWN, Pa., <span class="legendSpanClass"><span class="xn-chron">Jan. 8, 2026 /PRNewswire/ -- <b>Edelson Lechtzin LLP</b> is investigating potential violations  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/investigation-alert-edelson-lechtzin-llp-announces-an-investigation-of-anavex-life-sciences-corp-nasdaq-avxl-and-encourages-investors-with-substantial-losses-contact-the-firm-15404013</guid></item><item><title>INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL</title><pubDate>Thu, 08 Jan 2026 16:00:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-anavex-life-sciences-corp-avxl-15402715</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">NEW YORK, <span class="legendSpanClass"><span class="xn-chron">Jan. 8, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-anavex-life-sciences-corp-avxl-15402715</guid></item><item><title>INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL</title><pubDate>Thu, 01 Jan 2026 16:00:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-anavex-life-sciences-corp-avxl-15388186</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">NEW YORK, <span class="legendSpanClass"><span class="xn-chron">Jan. 1, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of   ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-anavex-life-sciences-corp-avxl-15388186</guid></item><item><title>INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL</title><pubDate>Thu, 11 Dec 2025 16:00:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-anavex-life-sciences-corp-avxl-15352812</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">NEW YORK, <span class="legendSpanClass"><span class="xn-chron">Dec. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of   ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-anavex-life-sciences-corp-avxl-15352812</guid></item><item><title>Anavex Life Sciences: So schnitt der Konzern im vergangenen Quartal ab</title><pubDate>Wed, 26 Nov 2025 06:35:06 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/anavex-life-sciences-so-schnitt-der-konzern-im-vergangenen-quartal-ab-15313810</link><description><![CDATA[<p><a href="https://www.finanzen.net/aktien/anavex_life_sciences_1-aktie">Anavex Life Sciences</a> lud am 25.11.2025 zur turnusmäßigen Finanzkonferenz und hat dort das Zahlenwerk zum jüngsten Quartal veröffentlicht, das am 30.09.2025 endete.Der Verlust je Aktie belief sich auf  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/anavex-life-sciences-so-schnitt-der-konzern-im-vergangenen-quartal-ab-15313810</guid></item><item><title>INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL</title><pubDate>Wed, 19 Nov 2025 01:56:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-anavex-life-sciences-corp-avxl-15289953</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">NEW YORK, <span class="legendSpanClass"><span class="xn-chron">Nov. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of   ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-anavex-life-sciences-corp-avxl-15289953</guid></item></channel></rss>
